Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 1/20 | 1.00 |
| ▸ | AKR1C2 | P52895 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 11/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.37 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.32 |
| ▸ | PTGIR | P43119 | 2/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | PTGFR | P43088 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Jasmonic Acid SCHEMBL114054 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL7113180 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL125395 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL12216372 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL7113179 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL3074832 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL4360733 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL5598513 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL1365044 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Jasmonic Acid SCHEMBL6734659 | 1.00 | AKR1C4 (1.00) | AKR1C4AKR1C3AKR1C2HTTPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| EP-3930460-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| CN-112638861-A | Process for preparing cis-alpha, beta-substituted cyclopentanones | 弗门尼舍有限公司 | 2021-04-09 | — | — | CN | claimed |
| WO-2020239954-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| CN-106518471-A | Nutrient solution for grape planting | 华蓥市德嘉葡萄专业合作社 | 2017-03-22 | — | — | CN | claimed |
| US-20160101083-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | BIORESPONSE, L.L.C. (US) | 2016-04-14 | — | — | US | claimed |
| US-20140037577-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | BIORESPONSE, L.L.C. | 2014-02-06 | — | — | US | claimed |
| US-8586621-B2 | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles | BIORESPONSE, L.L.C. | 2013-11-19 | — | — | US | claimed |
| WO-2012034825-A3 | FLUORINE GAS PLANT | SOLVAY SA (BE) | 2012-05-10 | — | — | WO | claimed |
| EP-1333022-B1 | Compounds containing derivatives of cyclopentane and their use to stimulate skin peeling | OREAL (FR) | 2011-12-07 | — | — | EP | claimed |
| US-20100055201-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | BIORESPONSE, L.L.C. | 2010-03-04 | — | — | US | claimed |
| WO-2008057253-A2 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | BIORESPONSE, L.L.C. (US) | 2008-05-15 | — | — | WO | claimed |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | claimed |
| EP-1333022-A2 | Compounds containing derivatives of cyclopentane and their use to stimulate skin peeling | L'OREAL (FR) | 2003-08-06 | — | — | EP | claimed |
| EP-0743985-B1 | METHOD FOR PREPARING CYCLIC KETONES | FIRMENICH & CIE (CH) | 2000-10-11 | — | — | EP | claimed |
| US-5667995-A | MICROORGANISM CULTURE, BETA-OXIDATION, BIOSYNTHESIS | FIRMENICH SA (CH) | 1997-09-16 | — | — | US | claimed |
| US-20250312349-A1 | COMPOSITION AND METHODS OF TREATING INTRACELLULAR PATHOGEN INFECTION | UNIV HOSPITALS CLEVELAND MEDICAL CENTER (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-03-06 | — | — | US | disclosed |
| WO-1996018742-A1 | METHOD FOR PREPARING CYCLIC KETONES | FIRMENICH S.A. (CH) | 1996-06-20 | — | — | WO | disclosed |
| US-3941828-A | Process for the preparation of cyclic ketones | FIRMENICH SA (CH) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160101083-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | CASP3, IDO1, INMT | AKR1C4 4234/4885AKR1C3 3259/4885AKR1C2 3590/4885 |
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | FABP2, FABP1, FASN | AKR1C4 1801/4885AKR1C3 1860/4885AKR1C2 1318/4885 |
| US-20100055201-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | CASP3, IDO1, INMT | AKR1C4 4234/4885AKR1C3 3259/4885AKR1C2 3590/4885 |
| US-20140037577-A1 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | CASP3, IDO1, INMT | AKR1C4 4234/4885AKR1C3 3259/4885AKR1C2 3590/4885 |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | CBR1, CBR3, DECR1 | AKR1C4 34/4885AKR1C3 23/4885AKR1C2 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.